76 results about "Tension headache" patented technology

Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient. A composition useful for practicing the methods of the invention is described which comprises at least one local anesthetic in a pharmaceutically acceptable carrier, wherein the composition is formulated for intranasal delivery. Cerebral neurovascular disorders include migraine and cluster headache. Muscular headaches include tension headaches and muscle contraction headaches. A kit comprising the composition and an intranasal applicator and a method of systemically delivering a pharmaceutically active agent to an animal are also included in the invention. Apparatus for directed intranasal administration of the compositions of the invention and for performing the methods of the invention are also described.

A device is for the electrotherapeutic treatment of headaches such as tension headaches and migraines. An electrode support (10) has a shape and is size selected so as to allow, independently from the subject, the excitation of the afferent paths of the supratrochlear (2) and supraorbital (3) nerves of the ophthalmic branch (1) of the trigeminal nerve. An electrical circuit includes a programmable signal generator suitable for creating pulses of a duration of between 150 and 450 microseconds with a maximum increase in intensity of 0 to 20 milliamperes at a rate of less than or equal to 40 microamperes per second and with a step up in intensity not exceeding 50 microamperes.

The invention is directed to topical formulations and methods of treating a migraines and / or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related migraines and related conditions associated with muscle tension and pain with a therapeutically effective amount of an ergot alkaloid, skeletal muscle relaxant, serotonin agonist, combinations thereof, pharmaceutically acceptable salt thereof, prodrugs thereof or derivative thereof.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and / or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and / or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

The present invention relates generally to dental appliances, and more specifically, to a unique bite guard that protects the teeth from the negative effects of teeth grinding or clenching, or other temporomandibular disorders which may include tension headaches, teeth fracture, cracking and / or loss. The application and configuration of the dental appliance is aesthetically superior to other configurations and arrangements and comprises of an outer shell that is small in configuration and is sized to fit the lower portion of a patient's lower front teeth. The dental appliance further includes an inner pliable layer that is in mating engagement with the inner anterior wall and the inner posterior wall of the outer shell. The inner pliable layer is also in mating engagement with the patient's front incisors and conforms to the patient's dentition.

Loxapine, amoxapine, or salts or prodrugs of either, is effective in alleviating pain, particularly headache pain such as migraine, cluster headaches and tension headaches. Preferably the loxapine or amoxapine is administered systemically, most preferably by inhalation.

An multipurpose mouthpiece assembly is disclosed for use in diagnosing and treating a variety of termporomandibular disorders. The assembly can include both a maxillary appliance and a mandibular appliance that are optionally configurable to function as a discluder, for diagnosing and treating wearers suffering from bruxism, tension headaches, and common migraine headaches, by preventing contact between opposing canine and posterior teeth and thereby reducing the intensity of clenching of the wearer's temporalis muscles. Alternatively, the two appliances are optionally configurable for use as a mandibular advancement device, for diagnosing and treating wearers suffering from obstructive sleep apnea by preventing excessive retrusion of the wearer's mandible. Alternatively, either the maxillary appliance or the mandibular appliance can be used individually to protect the teeth from nocturnal asymptomatic teeth grinding. In all cases, the appliance(s) can be readily adjusted to accommodate wearers whose maxillary and mandibular arches have a variety of sizes and shapes.

An intraoral discluder for preventing chronic tension headaches, common migraine headaches, and temporomandibular disorders that are caused or perpetuated by chronic activity of the temporalis muscle. The discluder includes a trough, contoured to encompass at least one maxillary or mandibular incisor, from which extends a protruding platform, for engagement by the opposing incisors. The trough can be retained on the teeth by any adaptable material than can flow around the teeth and then maintain its shape. Once in place in the wearer's mouth, one or two opposing incisors will come into contact with the platform prior to the upper and lower posterior and / or canine teeth coming into contact, regardless of the position of the mandible, thereby reducing the intensity of the activity of the temporalis muscle. In addition, a special post on the discluder's platform is engageable directly with one or more opposing incisors, to act as a stop and thereby inhibit excessive retrusive movement of the mandible and urge the mandible toward a more protrusive position. This can reduce the intensity of undesired clenching, and it can enhance the size of the wearer's pharyngeal airspace, thereby reducing the incidence and severity of snoring.

The invention discloses a polyvinyl chloride (PVC) cable sheath material and a preparation method thereof. The PVC cable sheath material comprises 100 parts of PVC resin, 30-50 parts of plasticizer, 3-7 parts of compound stabilizer, 20-40 parts of active calcium carbonate, 5-15 parts of kaolin, 5-15 parts of aluminum hydroxide, 3-6 parts of antimony trioxide, 3-5 parts of zinc borate and 0.5-1.5 parts of aromatizer. In the cable sheath rubber disclosed by the invention, through the optimal combination of aluminum hydroxide, antimony trioxide and zinc borate, the carbonization amount is improved by approximate 50%; the smoke generation amount during naked flame combustion is reduced by 30-50%, and the limiting oxygen index (LOI) is improved to 33; by selecting a proper plasticizer, the material has excellent low-temperature and high-temperature resistance at the same time, and the use temperature of the material is (-30)-90 DEG C; and a mint-flavored essential oil aromatizer is added to the material, so that the obtained product has aromatic odor and has the actions of eliminating nausea, nervousness and tension headache and dispelling mosquito.

A Chinese medicine for treating trigeminal neuralgia, headach, etc is prepared from 6 Chinese-medicinal materials including Chuan-xiong rhizome, gast rodia tuber, asarum herb, white mustard seed, etc. Its advantages are high curative effect (97.4%) and low toxic by-effect.

A hand held temple massager having a handle and two spaced-apart arms extending in substantially the same plane from an end of the handle. Each arm includes a distal portion and a proximal portion, the latter integrally connected to the handle. The distal portion of each arm includes means to capture and retain a pressure member with temple-engaging portion for applying pressure directly to the temple area of a user to treat and prevent a tension headache. The massager includes pressure adjustment means disposed between said first and second arms to tailor the pressure applied by the massager, and may also include a small vibrating motor powered by batteries.

The invention relates to nutritional food and medicines, in particular to a composition, which can clear the brain, relieve uneasiness and adjust the nerves while easing tension headaches, help to improve sleep and have no side effect. The composition comprises 2-98 parts by weight of Armillaria mellea and 2-98 parts by weight of one or several of Melissa, lavender, chrysanthemum and jasmine.

The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms and / or headaches (e.g., migraine, cluster headache, and tension headache) by administering an anti-CGRP antagonist antibody. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.

A liposomal encapsulated solution of L-theanine is sprayed onto the sublingual membrane of a subject. The method may be used in the treatment of stress, tension headaches, attention deficit disorder (ADD), attention deficit disorder hyperactivity (ADHD), claustrophobia, hyperactivity, and anxiety.

The present invention provides an improved method and apparatus for use in diagnosing temporomandibular disorders. The apparatus includes separate maxillary and mandibular appliances, which are sized and configured to fit over and be retained on a subject's incisors. The two appliances both include generally flat, T-shaped platforms that face each other in a confronting relationship for all possible mandibular movements, including excursive movement and protrusive / retrusive movement. When properly fitted on the subject's opposing incisors, the two appliances effectively prevent contact between the subject's opposing upper and lower teeth, including the posterior and canine teeth, and thereby reduce the intensity of clenching of the temporalis muscles. The apparatus thereby can be used to provide an inexpensive way for determining whether an intraoral discluder of this kind will be effective in relieving tension headaches, common migraine headaches, or other temporomandibular disorders.

The present invention is a manual, medicine, therapy technique that provides a guide to evaluate soft tissue impairment and guidelines to treat muscle tension, muscle pain, soft tissue pain, trigger points, and tension headaches through stimulating the Golgi Tendon Organs.

The invention relates to a headache treatment instrument, which is composed of a bracket, a far-infrared electric heating source, a control circuit, etc. The heating source is installed on the bracket near the temple of the human body, and the method of local high-temperature electric heating in a small area is used to quickly and thoroughly relieve headaches. stop. It is used for the treatment of various headaches such as migraines and tension headaches.

The invention discloses a traditional Chinese medicinal pill used for treating tension headache and a preparation method thereof and belongs to the field of traditional Chinese medicines. The traditional Chinese medicinal pill used for treating tension headache is prepared from the following effective ingredient raw materials by weight: 66-82g of American ginseng, 63-78g of fructus lycii, 60-75g of dried rehmannia root, 57-70g of black sesame, 55-68g of wheat produced in Jianghuai region, 53-65g of polygonatum kingianum, 50-62g of Chinese dates, 43-59g of radix bupleuri, 40-55g of ligusticum wallichii, 38-52g of salviae miltiorrhizae, 35-48g of angelica root, 32-45g of Chinese angelica, 30-42g of cortex albiziae, 28-40g of sophora flower, 25-37g of curcuma aromatica, 23-35g of lindera aggregata, 20-33g of arisaema cum bile, 18-30g of arabian jasmine flower, 15-28g of polygonum multiflorum, 12-25g of nacre mother of pearl, 9-22g of selfheal, 6-18g of tuber fleeceflower stem, 4-12g of liquorice and 2-8g of centipedes. The traditional Chinese medicinal pill used for treating tension headache has the advantages that the selected medicinal materials are compatible and complementary each other, symptomatic treatment is carried out according to pathogenesis, the effects of tonifying the liver and kidney, soothing liver-qi stagnation, tonifying qi and nourishing yin, replenishing blood and activating blood as well as tranquilizing by nourishing the heart are realized, absorption effect is good, curative effect is obvious, no toxic or side effect is produced, no clinical adverse reaction is caused, and clinical verification shows that curative ratio on the tension headache is high.

The invention belongs to healthcare products, and in particular relates to compound agilawood essential oil for releasing tension headache. The compound agilawood essential oil is prepared by uniformly mixing the agilawood essential oil, geranium essential oil, clary sage essential oil, rosemary essential oil and grape seed oil. In the invention, scientific compatibility of natural plant extracts is carried out, thus the curative effects of calming, soothing the nerves, cheering mood, releasing tense mood and the like are effectively realized, and the tension headache caused by tension or worriment is released; in addition, the compound agilawood essential oil disclosed by the invention has the characteristics of good curative effects, no toxic and side effects, simple use method and the like.

The invention discloses a Chinese medicinal preparation for treating cephalodynia and its preparing process, wherein the medicament is prepared from nine kinds of Chinese herbs including cyperus tuber, radix paeoniae rubrathe, Ligusticum wallichii and Chinese angelica root. The medicament can be made into the dosage forms of capsules, tablets, granules or liquids.

The invention discloses a Chinese herbal medicine treating tension headache, which is characterized in that: twelve kinds of Chinese herbal medicine of angelica, bupleurum, rhizoma ligustici wallichii, ephedra, safflower, notopterygium, pubescent angelica, liquorice, tangerine peel, angelica sinensis, kudzu and peach kernel are used as raw material to produce clinically accepted formulation such as capsules, tablets and granule through directly or indirectly adding pharmaceutically accepted excipient of conventional process. The Chinese herbal medicine has the advantages of dispelling wind and activating blood, nourishing blood and calming the hyperactive liver and dredging channels and taking away pain, fully playing the role of treating both manifestation and root cause of disease and having small side effect, having good result for treating tension headache, which cannot easily reoccur.

The invention is directed to topical formulations and methods of treating a migraines and / or cluster headaches, muscle sprains, muscle spasms, spasticity, tension headaches, tension related migraines and related conditions associated with muscle tension and pain with a therapeutically effective amount of an ergot alkaloid, skeletal muscle relaxant, serotonin agonist, combinations thereof, pharmaceutically acceptable salt thereof, prodrugs thereof or derivative thereof.

A semi-custom intraoral discluder device for preventing chronic tension and common migraine headaches and temporomandibular disorders that are caused or perpetuated by chronic activity of the temporalis muscle. The discluder includes a trough, contoured to encompass at least one maxillary or mandibular incisor, from which extends a protrusion, typically of a dome shape. The trough can be retained on the teeth by any adaptable material which can flow around the teeth and then maintain its shape. The adaptation of the retentive material can be performed by the end user, health care provider, or anyone trained in the art. Once in place in the wearer's mouth, one or two opposing incisor teeth will come into contact with the protrusion prior to the upper and lower posterior and / or canine teeth coming into contact, regardless of the position of the mandible, thereby reducing the intensity of the activity of the temporalis muscle.